Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab

URN:NBN:SI:doc-A5U2ASX62014Dittrich, ChristianKienzer, GabrieleKönigsberg, RobertMaierhofer, JuliaSteininger, Tanjadocuments/doc/A/URN_NBN_SI_doc-A5U2ASX6_001.pdfdocuments/doc/A/URN_NBN_SI_doc-A5U2ASX6_001.txt248articlestr. 184-188, VI1318-2099276562176URN:NBN:SI:doc-A5U2ASX6engslvAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYbreastdojkeonkologijarak (medicina)therapyzdravljenjeLong-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab